By David Downs
Public-health researchers say the federal government is slowing the search for cures to breast, colon, prostate and brain cancers, as well as Huntington’s disease, Alzheimer’s, and HIV, because the research involves cannabis.
That’s the takeaway from the 21st annual symposium of the International Cannabinoid Research Society, which was held earlier this month in Illinois. Researchers stacked the program with talks not only about cannabis’s palliative properties but also its curative efficacy. The event, sponsored by the National Institute on Drug Abuse, was held the same week the Drug Enforcement Administration reiterated its stance that marijuana has no accepted medical use.
“It was really interesting,” said Amanda Reiman, who holds a doctorate from the UC Berkeley School of Social Welfare and presented at the symposium. “At the same time [that] the DEA was publicly declaring that cannabis has no medical value, I was surrounded by the most brilliant minds in the world talking about nothing but the medical value of cannabinoids.”
She said the frustration “was something you could feel in the air.”
Read complete article here: